exphar is a company registered in Belgium, specializing in the manufacture and distribution of sterile and non-sterile generic drugs intended for African markets.
Our products are by far more affordable than specialty reference products, although they are produced to the same high standards of the EU Good Medicines Practice (GMP) and receive the same scrutiny. Our production sites are regularly audited by European Health Authorities. All our products are tested for bioequivalence and bioavailability in clinical studies that demonstrate their high quality.
We are licensed as:
- Manufacturer: EUGMP issued by the European Union: MIA (Manufacturing and Import Authorization) 934H BE / GMP / 2015/022
- Distributor: EUGDP issued by the European Union: WDA (Wholesale Distribution Authorization) 9802 BE / PIB / 2015/015
We have remained steadfast in our commitment for 40 years, and we will continue to develop pharmaceutical socialities to make health accessible to more people. We owe it to ourselves as a leader in this market.
Today we have become a major actor in the health sector in Sub-Saharan Africa.
IMS Ranking 2020 – Africa (Zone CFA) :
- Top 10 in turnover
- 3rd for units sold